Skip to content
Relatix Health

Relatix Health

Radically different

  • Participate
    • Start here
  • Services
    • Tests to participate in
  • Resources
  • About
    • Our Vision – A radically different future
    • Our mission – personalised lifelong support
    • News
    • FAQ
    • Contact
    • Trust and Privacy
    • Support us
  • Log in / Sign up
Posted on April 22, 2026 by admin

Transcranial Photobiomodulation (tPBM) for Somatic Symptoms in Treatment-Resistant Depression

Conditions: Treatment-resistant Depression (TRD); Major Depression Disorder

Interventions: Device: transcranial photobiomodulation

Sponsors: Taipei Veterans General Hospital, Taiwan

Recruiting
CategoriesClinicalTrials.gov TagsChronic depression, Depression, Healthcare provider, Medical device, Mood and emotional regulation, News Approved

Post navigation

Previous PostPrevious Efficacy and Safety of Sertraline Combined With Lactobacillus Crispatus in Adolescents With Depression : A Multicenter Randomized Controlled Trial
Next PostNext Pilot Randomized Trial of BA-GSH in VA PC-MHI
Relatix Health

Relatix Health helps people understand their minds, explore relevant support and take part in research on their own terms. We connect lived experience with responsible research while protecting privacy, dignity and choice.

For researchers, clinicians and organisations, visit our sister site, Relatix Bio.

Take part

Start here Participate Tests to participate in Log in or sign up

Find support

Resources Services FAQ I need help now

Our commitments

Our Vision Our Mission Trust and Privacy

About

About us News Support us Contact

© 2026 Relatix Health. All rights reserved.